US Stock MarketDetailed Quotes

Cogent Biosciences (COGT)

Watchlist
  • 34.530
  • +0.430+1.26%
Close May 12 16:00 ET
  • 34.530
  • 0.0000.00%
Post 16:10 ET
5.90BMarket Cap-15.91P/E (TTM)

Cogent Biosciences (COGT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
38.27%103.61M
20.81%333.36M
34.94%99.49M
10.53%83.36M
17.39%75.58M
20.08%74.93M
32.58%275.94M
26.63%73.73M
26.58%75.41M
36.75%64.39M
Selling and administrative expenses
137.25%28.24M
46.91%63.58M
104.76%23.93M
21.75%14.37M
32.56%13.38M
22.73%11.9M
25.91%43.28M
22.93%11.69M
24.83%11.8M
22.88%10.09M
-General and administrative expense
137.25%28.24M
46.91%63.58M
104.76%23.93M
21.75%14.37M
32.56%13.38M
22.73%11.9M
25.91%43.28M
22.93%11.69M
24.83%11.8M
22.88%10.09M
Research and development costs
19.57%75.37M
15.96%269.78M
21.78%75.56M
8.45%68.99M
14.57%62.2M
19.59%63.03M
33.90%232.66M
27.35%62.05M
26.91%63.61M
39.68%54.29M
Operating profit
-38.27%-103.61M
-20.81%-333.36M
-34.94%-99.49M
-10.53%-83.36M
-17.39%-75.58M
-20.08%-74.93M
-32.58%-275.94M
-26.63%-73.73M
-26.58%-75.41M
-36.75%-64.39M
Net non-operating interest income expense
116.63%6.4M
-35.72%11.63M
8.53%4.19M
-49.19%2.43M
-61.82%2.06M
-27.24%2.95M
38.32%18.09M
-0.28%3.86M
13.84%4.78M
96.75%5.39M
Non-operating interest income
157.72%7.61M
-18.79%14.69M
41.93%5.48M
-18.66%3.89M
-56.00%2.37M
-27.24%2.95M
38.32%18.09M
-0.28%3.86M
13.84%4.78M
96.75%5.39M
Non-operating interest expense
--1.21M
--3.06M
--1.29M
--1.46M
--314K
--0
--0
--0
--0
--0
Other net income (expense)
-2,700.00%-140K
-461.50%-7.2M
-468.94%-7.19M
-400.00%-3K
-113.64%-6K
-400.00%-5K
-24.63%1.99M
27,928.57%1.95M
1K
-83.58%44K
Special income (charges)
----
---7.18M
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
--7.18M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-2,700.00%-140K
-101.00%-20K
-100.31%-6K
-400.00%-3K
-113.64%-6K
-400.00%-5K
-24.63%1.99M
27,928.57%1.95M
--1K
-83.58%44K
Income before tax
-35.24%-97.35M
-28.56%-328.94M
-50.89%-102.49M
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
Income tax
Net income
-35.24%-97.35M
-28.56%-328.94M
-50.89%-102.49M
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
Net income continuous Operations
-35.24%-97.35M
-28.56%-328.94M
-50.89%-102.49M
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
Minority interest income
Net income attributable to the parent company
-35.24%-97.35M
-28.56%-328.94M
-50.89%-102.49M
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
Preferred stock dividends
-1.99%-12.51M
Other preferred stock dividends
Net income attributable to common stockholders
-35.24%-97.35M
-28.56%-328.94M
-50.89%-102.49M
-14.58%-80.93M
-24.73%-73.53M
-56.23%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
Basic earnings per share
-1.92%-0.53
-11.34%-2.16
-3.53%-0.6367
3.85%-0.5
-23.26%-0.53
-6.12%-0.52
0.00%-1.94
2.39%-0.6149
18.75%-0.52
27.12%-0.43
Diluted earnings per share
-1.92%-0.53
-11.34%-2.16
-3.53%-0.6367
3.85%-0.5
-23.26%-0.53
-6.12%-0.52
0.00%-1.94
2.39%-0.6149
18.75%-0.52
27.12%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 38.27%103.61M20.81%333.36M34.94%99.49M10.53%83.36M17.39%75.58M20.08%74.93M32.58%275.94M26.63%73.73M26.58%75.41M36.75%64.39M
Selling and administrative expenses 137.25%28.24M46.91%63.58M104.76%23.93M21.75%14.37M32.56%13.38M22.73%11.9M25.91%43.28M22.93%11.69M24.83%11.8M22.88%10.09M
-General and administrative expense 137.25%28.24M46.91%63.58M104.76%23.93M21.75%14.37M32.56%13.38M22.73%11.9M25.91%43.28M22.93%11.69M24.83%11.8M22.88%10.09M
Research and development costs 19.57%75.37M15.96%269.78M21.78%75.56M8.45%68.99M14.57%62.2M19.59%63.03M33.90%232.66M27.35%62.05M26.91%63.61M39.68%54.29M
Operating profit -38.27%-103.61M-20.81%-333.36M-34.94%-99.49M-10.53%-83.36M-17.39%-75.58M-20.08%-74.93M-32.58%-275.94M-26.63%-73.73M-26.58%-75.41M-36.75%-64.39M
Net non-operating interest income expense 116.63%6.4M-35.72%11.63M8.53%4.19M-49.19%2.43M-61.82%2.06M-27.24%2.95M38.32%18.09M-0.28%3.86M13.84%4.78M96.75%5.39M
Non-operating interest income 157.72%7.61M-18.79%14.69M41.93%5.48M-18.66%3.89M-56.00%2.37M-27.24%2.95M38.32%18.09M-0.28%3.86M13.84%4.78M96.75%5.39M
Non-operating interest expense --1.21M--3.06M--1.29M--1.46M--314K--0--0--0--0--0
Other net income (expense) -2,700.00%-140K-461.50%-7.2M-468.94%-7.19M-400.00%-3K-113.64%-6K-400.00%-5K-24.63%1.99M27,928.57%1.95M1K-83.58%44K
Special income (charges) -------7.18M------------------0------------
-Less:Other special charges ------7.18M--------------------------------
Other non- operating income (expenses) -2,700.00%-140K-101.00%-20K-100.31%-6K-400.00%-3K-113.64%-6K-400.00%-5K-24.63%1.99M27,928.57%1.95M--1K-83.58%44K
Income before tax -35.24%-97.35M-28.56%-328.94M-50.89%-102.49M-14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M
Income tax
Net income -35.24%-97.35M-28.56%-328.94M-50.89%-102.49M-14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M
Net income continuous Operations -35.24%-97.35M-28.56%-328.94M-50.89%-102.49M-14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M
Minority interest income
Net income attributable to the parent company -35.24%-97.35M-28.56%-328.94M-50.89%-102.49M-14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M
Preferred stock dividends -1.99%-12.51M
Other preferred stock dividends
Net income attributable to common stockholders -35.24%-97.35M-28.56%-328.94M-50.89%-102.49M-14.58%-80.93M-24.73%-73.53M-56.23%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M
Basic earnings per share -1.92%-0.53-11.34%-2.16-3.53%-0.63673.85%-0.5-23.26%-0.53-6.12%-0.520.00%-1.942.39%-0.614918.75%-0.5227.12%-0.43
Diluted earnings per share -1.92%-0.53-11.34%-2.16-3.53%-0.63673.85%-0.5-23.26%-0.53-6.12%-0.520.00%-1.942.39%-0.614918.75%-0.5227.12%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More